GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QuidelOrtho Corp (NAS:QDEL) » Definitions » Cyclically Adjusted PB Ratio

QuidelOrtho (QuidelOrtho) Cyclically Adjusted PB Ratio : 1.55 (As of May. 14, 2024)


View and export this data going back to 1992. Start your Free Trial

What is QuidelOrtho Cyclically Adjusted PB Ratio?

As of today (2024-05-14), QuidelOrtho's current share price is $44.18. QuidelOrtho's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $28.51. QuidelOrtho's Cyclically Adjusted PB Ratio for today is 1.55.

The historical rank and industry rank for QuidelOrtho's Cyclically Adjusted PB Ratio or its related term are showing as below:

QDEL' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.48   Med: 6.19   Max: 35.35
Current: 1.48

During the past years, QuidelOrtho's highest Cyclically Adjusted PB Ratio was 35.35. The lowest was 1.48. And the median was 6.19.

QDEL's Cyclically Adjusted PB Ratio is ranked better than
61.94% of 465 companies
in the Medical Devices & Instruments industry
Industry Median: 2.19 vs QDEL: 1.48

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

QuidelOrtho's adjusted book value per share data for the three months ended in Mar. 2024 was $49.458. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $28.51 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


QuidelOrtho Cyclically Adjusted PB Ratio Historical Data

The historical data trend for QuidelOrtho's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QuidelOrtho Cyclically Adjusted PB Ratio Chart

QuidelOrtho Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.02 19.67 10.35 4.25 2.68

QuidelOrtho Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.02 3.44 2.82 2.68 1.68

Competitive Comparison of QuidelOrtho's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, QuidelOrtho's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QuidelOrtho's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QuidelOrtho's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where QuidelOrtho's Cyclically Adjusted PB Ratio falls into.



QuidelOrtho Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

QuidelOrtho's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=44.18/28.51
=1.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QuidelOrtho's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, QuidelOrtho's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=49.458/129.4194*129.4194
=49.458

Current CPI (Mar. 2024) = 129.4194.

QuidelOrtho Quarterly Data

Book Value per Share CPI Adj_Book
201406 6.414 100.560 8.255
201409 6.318 100.428 8.142
201412 7.116 99.070 9.296
201503 7.291 99.621 9.472
201506 6.790 100.684 8.728
201509 6.566 100.392 8.465
201512 6.562 99.792 8.510
201603 6.138 100.470 7.907
201606 5.960 101.688 7.585
201609 6.027 101.861 7.658
201612 6.099 101.863 7.749
201703 6.632 102.862 8.344
201706 6.362 103.349 7.967
201709 6.441 104.136 8.005
201712 6.575 104.011 8.181
201803 8.838 105.290 10.863
201806 9.459 106.317 11.514
201809 9.878 106.507 12.003
201812 10.805 105.998 13.192
201903 11.574 107.251 13.966
201906 12.313 108.070 14.746
201909 12.828 108.329 15.325
201912 13.371 108.420 15.961
202003 14.411 108.902 17.126
202006 14.582 108.767 17.351
202009 20.202 109.815 23.809
202012 31.513 109.897 37.111
202103 35.017 111.754 40.552
202106 33.893 114.631 38.265
202109 39.213 115.734 43.850
202112 46.284 117.630 50.923
202203 57.710 121.301 61.572
202206 73.427 125.017 76.013
202209 72.656 125.227 75.089
202212 74.316 125.222 76.807
202303 75.023 127.348 76.243
202306 74.888 128.729 75.290
202309 74.352 129.860 74.100
202312 75.051 129.419 75.051
202403 49.458 129.419 49.458

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


QuidelOrtho  (NAS:QDEL) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


QuidelOrtho Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of QuidelOrtho's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


QuidelOrtho (QuidelOrtho) Business Description

Traded in Other Exchanges
Address
9975 Summers Ridge Road, San Diego, CA, USA, 92121
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make better decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.
Executives
Louise Brandy officer: SVP, Chief Information Officer 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Patrick Klein officer: Chief Administrative Officer 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Christopher M Smith director 125 CONSTITUTION DRIVE, MENLO PARK CA 94025
Edward L. Michael director 618 SHERIDAN SQUARE, EVANSTON IL 60202
William J. Ferenczy officer: SVP, Cardio/Metabolic Unit 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Werner Kroll officer: SVP, Research and Development 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Kenneth F Buechler director
Robert R. Schmidt director C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Tamara A. Ranalli officer: SVP, Molecular Bus. Unit 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Stephen H. Wise director C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Robert Joseph Bujarski officer: See Remarks C/O QUIDEL CORPORATION, 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Wilkins Joseph D Jr. director 82414 PUCCINI DRIVE, INDIO CA 92203
Michelle A. Hodges officer: SVP, General Counsel 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Douglas C Bryant director, officer: Chairman & CEO C/O QUIDEL CORPORATION, 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Joseph M Busky officer: Chief Financial Officer 1717 DEERFIELD ROAD, DEERFIELD IL 60015